We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 01, 2020

Weekly Semaglutide vs Daily Sitagliptin in Type 2 Diabetes

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Efficacy and Safety of Once-Weekly Semaglutide vs Once-Daily Sitagliptin as Add-on to Metformin in Patients With Type 2 Diabetes (SUSTAIN China): A 30-week Double-Blind, Phase 3a, Randomised Trial
Diabetes Obes Metab 2020 Oct 19;[EPub Ahead of Print], L Ji, X Dong, Y Li, Y Li, S Lim, M Liu, Z Ning, S Rasmussen, T Vang Skjøth, G Yuan, FG Eliaschewitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading